{
    "nct_id": "NCT05940272",
    "official_title": "Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers",
    "inclusion_criteria": "Hematologists\n\n* Currently a hemotologic oncologist providing care to patients with DLBCL\n\nPatients\n\n* Per medical record, is being treated by a hematologic oncologist participating in this study\n* Per medical record, has a diagnosis of DLBCL including DLBCL-transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL) which are histologically similar and clinically treated as large-cell lymphoma\n* Per medical record, relapse/ refractory disease within 12 months of 4 cycles of first line therapy OR relapse after 2 cycles of later line therapy or autologous stem cell transplant (ASCT)\n* Self-identify as Black and/or White\n* Per medical record, 18 years of age or older\n* Per self-report, fluent in English** ** Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify English fluency necessary for participation in the study:\n\n  1. How well do you speak English? (must respond \"very well\" or \"well\" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)\n  2. What is your preferred language for healthcare? (must respond English)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "Hematologists\n\n* Per self-report, planning to leave the cancer center in the next 12 months\n\nPatients\n\n* Cognitively impaired as demonstrated by (Blessed Orientation- Memory- Concentration (BOMC) score of â‰¥ 11\n* Per research staff judgment and/or self-report, too ill or weak to complete study procedures\n* Per medical record or self-report, receiving hospice care at the time of enrollment",
    "miscellaneous_criteria": ""
}